Voltaren Ophthalmic is a brand name of diclofenac ophthalmic, approved by the FDA in the following formulation(s):
VOLTAREN (diclofenac sodium - solution/drops; ophthalmic)
Manufacturer: NOVARTIS
Approval date: March 28, 1991
Strength(s): 0.1% [RLD][AT]
Has a generic version of Voltaren Ophthalmic been approved?
Yes. The following products are equivalent to Voltaren Ophthalmic:
diclofenac sodium solution/drops; ophthalmic
Manufacturer: AKORN
Approval date: April 17, 2008
Strength(s): 0.1% [AT]
Manufacturer: ALCON PHARMS LTD
Approval date: February 6, 2008
Strength(s): 0.1% [AT]
Manufacturer: APOTEX INC
Approval date: November 13, 2008
Strength(s): 0.1% [AT]
Manufacturer: BAUSCH AND LOMB
Approval date: December 28, 2007
Strength(s): 0.1% [AT]
Manufacturer: NEXUS PHARMS
Approval date: December 28, 2007
Strength(s): 0.1% [AT]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Voltaren Ophthalmic. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Voltaren Ophthalmic.
See also...
- Voltaren Drops Consumer Information (Wolters Kluwer)
- Voltaren Ophthalmic Consumer Information (Cerner Multum)
- Voltaren Ophthalmic Advanced Consumer Information (Micromedex)
- Diclofenac Drops Consumer Information (Wolters Kluwer)
- Diclofenac ophthalmic Consumer Information (Cerner Multum)
- Vofenal Advanced Consumer Information (Micromedex)
- Voltaren Ophtha Advanced Consumer Information (Micromedex)
- Diclofenac Ophthalmic Advanced Consumer Information (Micromedex)
No comments:
Post a Comment